Literature DB >> 16258936

Expression of avian C-terminal binding proteins (Ctbp1 and Ctbp2) during embryonic development.

Nick Van Hateren1, Tom Shenton, Anne-Gaëlle Borycki.   

Abstract

C-terminal binding proteins (CtBPs) are transcriptional corepressors of mediators of Notch, Wnt, and other signalling pathways. Thus, they are potential players in the control of several developmentally important processes, including segmentation, somitogenesis, and neural tube and limb patterning. We have cloned the avian orthologues of Ctbp1 and Ctbp2 and examined their expression pattern by whole-mount in situ hybridization between Hamburger and Hamilton (HH) stages 3 and 24. Both Ctbp genes show similar expression patterns during embryonic development, and both are detected from HH stage 3 in the developing central nervous system, by HH stage 7 in the paraxial mesoderm and later in the limb bud. In most places, Ctbp1 and Ctbp2 are expressed in overlapping domains. However, there are interesting domains and/or temporal expression patterns that are specific to each Ctbp gene. For instance, Ctbp1 is predominantly expressed in the epiblast, whereas Ctbp2 is in the primitive streak at HH stage 3. However, by HH stage 4, both genes are found in the primitive streak and in the ectoderm. Similarly, although both genes display similar expression patterns in early somitogenesis, in mature somites, Ctbp1 transcripts are located in myotomal cells, whereas Ctbp2 transcripts are observed in dermomyotomal cells. Finally, we found that emigrating neural crest cells express Ctbp2, whereas dorsal root ganglia express Ctbp1. These data suggest that Ctbp1 and Ctbp2 may be functionally redundant in some tissues and have unique functions in other tissues. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16258936     DOI: 10.1002/dvdy.20612

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  8 in total

Review 1.  Evolutionary functional analysis and molecular regulation of the ZEB transcription factors.

Authors:  Alexander Gheldof; Paco Hulpiau; Frans van Roy; Bram De Craene; Geert Berx
Journal:  Cell Mol Life Sci       Date:  2012-02-21       Impact factor: 9.261

2.  CtBP2 downregulation during neural crest specification induces expression of Mitf and REST, resulting in melanocyte differentiation and sympathoadrenal lineage suppression.

Authors:  Hongzi Liang; Donna M Fekete; Ourania M Andrisani
Journal:  Mol Cell Biol       Date:  2011-01-03       Impact factor: 4.272

3.  C-terminal binding proteins are essential pro-survival factors that undergo caspase-dependent downregulation during neuronal apoptosis.

Authors:  Trisha R Stankiewicz; Emily K Schroeder; Natalie A Kelsey; Ron J Bouchard; Daniel A Linseman
Journal:  Mol Cell Neurosci       Date:  2013-07-13       Impact factor: 4.314

Review 4.  The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.

Authors:  Melanie A Blevins; Mingxia Huang; Rui Zhao
Journal:  Mol Cancer Ther       Date:  2017-06       Impact factor: 6.261

5.  Developmental expression and phylogenetic conservation of alternatively spliced forms of the C-terminal binding protein corepressor.

Authors:  Priya Mani-Telang; David N Arnosti
Journal:  Dev Genes Evol       Date:  2006-11-21       Impact factor: 0.900

6.  A novel iterative mixed model to remap three complex orthopedic traits in dogs.

Authors:  Meng Huang; Jessica J Hayward; Elizabeth Corey; Susan J Garrison; Gabriela R Wagner; Ursula Krotscheck; Kei Hayashi; Peter A Schweitzer; George Lust; Adam R Boyko; Rory J Todhunter
Journal:  PLoS One       Date:  2017-06-14       Impact factor: 3.240

7.  Complex and dynamic patterns of Wnt pathway gene expression in the developing chick forebrain.

Authors:  Robyn Quinlan; Manuela Graf; Ivor Mason; Andrew Lumsden; Clemens Kiecker
Journal:  Neural Dev       Date:  2009-09-04       Impact factor: 3.842

8.  Expression and prognostic significance of CTBP2 in human gliomas.

Authors:  Yong Wang; Shusheng Che; Gang Cai; Yuchao He; Jialei Chen; Wei Xu
Journal:  Oncol Lett       Date:  2016-08-11       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.